Built around Nepal's requirements
We plan each study around Nepal's approval path from the first conversation: classifying the study, the Nepal rationale, a Nepalese principal investigator, trial registration, NHRC ethics review and DDA permission.
Clinical trials in Nepal
Clinical research support for pharmaceutical and medical device innovators in Nepal, from regulatory submission and study start-up through monitoring and close-out.
For sponsors, CROs and research institutions.

Start here
For sponsors and CROs bringing a study to Nepal, we coordinate the work from classification through ethics review, DDA permission and registration to site readiness. NHRC, DDA and the institutions make the approval decisions. The scope, the people responsible and the timeline are agreed in writing before work begins.
Ask about the start-up packageWhy us
We plan each study around Nepal's approval path from the first conversation: classifying the study, the Nepal rationale, a Nepalese principal investigator, trial registration, NHRC ethics review and DDA permission.

Consent forms and participant materials can be translated into Nepali, with back-translation where the ethics committee or sponsor requires it. Working with site staff in their own language supports recruitment, retention and data quality.
One coordinator follows your study from the first brief. Specialists and partners are brought in only where your scope needs them, and every responsibility is agreed in writing before work starts.
We manage investigational product import, cold chain and sample shipment. During start-up we identify which import and transfer permissions your study needs, so shipments are planned around them.
Services

Country and site feasibility, enrolment estimates, budgets and timelines for Nepal.
NHRC and DDA submissions, trial registration, and consent form translation.
Site contracts, essential documents, GCP training and site initiation.

Investigational product import, cold chain, lab kits and sample shipment.
Project management, on-site and remote monitoring, and site management support.

Recruitment plans based on real site data, with culturally adapted participant materials.
SAE reporting to the ethics board and sponsor within required timelines.

Data management, Trial Master File, audits and inspection readiness.
Close-out visits, product reconciliation, final reports and archiving.
Study types
Drug trials, starting with classification, NHRC ethics review and DDA permission. Early-phase studies need specific assessment of the phase, safety evidence and site infrastructure.
Trials where cold-chain, import and safety-reporting requirements are identified during start-up.
Studies where site selection depends on verified oncology capacity and the safety requirements of the protocol.
Clinical investigations, assessed for the specific device, its intended use and the applicable regulatory route.
The Nepal pathway
A planning framework, not a fixed sequence. Several steps are prepared in parallel, and the order for your study needs confirming with NHRC, DDA and the institution.

Summary of NHRC's National Ethical Guidelines for Health Research in Nepal 2022. Confirm current requirements with NHRC and DDA for your study.
Read the full pathwayThe pathway depends on design, phase and product. Early-phase and device studies carry additional conditions.
Externally sponsored studies must show why Nepal was chosen, including evidence the research could not be done in the sponsor's country.
International collaborations need a Nepalese principal investigator who carries local legal, technical and ethical responsibility.
Register the trial in a WHO-accredited registry; the registration number goes in with your NHRC ethics submission.
Clinical trials are reviewed by NHRC's Ethical Review Board through its online review platform (IRERP).
DDA permission under the Drug Act is required in addition to ethics approval, before the trial starts.
NHRC 2022 (section 4.5) sets Ethical Review Board notification of serious adverse events within 48 hours and a detailed report within two weeks. Check the protocol, approval conditions and DDA instructions for other reporting duties.
Planning guides

How Nepal Health Research Council (NHRC) ethics review and Department of Drug Administration (DDA) permission fit together for a clinical trial, how to test whether a CRO in Nepal can manage both, and how Nepal Clinical Research supports studies through them.
Read the guide
What a clinical research organisation (CRO) in Nepal should help with, the questions to ask before you engage one, and the responsibilities that stay with the sponsor.
Read the guide
How the Nepal Clinical Trials Registry (NCTR) relates to WHO's registry network, why journals may also need a Primary Registry record, and how registration differs from ethics approval.
Read the guidePlease do not send patient information or confidential protocol documents.